Rabi Hanna: Gene Therapy Is Transforming Sickle Cell Disease
Rabi Hanna, Chairman, Department of Pediatric hematology-oncology and BMT at Cleveland Clinic Children’s at Cleveland Clinic, shared a post on LinkedIn:
“Today, on World Sickle Cell Day, I had the distinct honor of speaking at the Dutch Sickle Cell event in Amsterdam.
A special thank you to Erfan Nur for the invitation and the opportunity to join this critical conversation. It is a privilege to present an update on the rapidly evolving landscape of sickle cell gene therapy
While the scientific advancements we are seeing are groundbreaking, our work is far from finished.
The true measure of our success will be ensuring that these potentially curative treatments are accessible to everyone who needs them, regardless of geography or socioeconomic status.
Thank you to the Dutch SCD community for hosting such an inspiring event. Let’s continue pushing the boundaries of science while fighting for equitable care.”

Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery